Filter
1427
Text search:
drug
approval
Featured
Recommendations
95
New Publications
409
Language
Document type
No document type
838
Studies & Reports
258
Guidelines
180
Manuals
61
Strategic & Response Plan
40
Fact sheets
26
Training Material
15
Resource Platforms
4
Situation Updates
3
Brochures
1
Infographics
1
Countries / Regions
India
93
Global
47
Uganda
43
Kenya
42
Nigeria
37
South Africa
36
Malawi
34
Ethiopia
31
Nepal
28
Western and Central Europe
28
Myanmar / Burma
26
Tanzania
25
Sierra Leone
24
Liberia
23
Ghana
22
Zambia
22
Ukraine
22
Bangladesh
21
Rwanda
20
Namibia
19
Latin America and the Carribbean
18
Lesotho
16
Zimbabwe
14
Africa
14
South–East Asia Region
13
Eastern Europe
12
Botswana
11
Congo, Democratic Republic of
9
Burkina Faso
8
Philippines
8
Cambodia
8
Asia
8
Senegal
7
Thailand
6
Pakistan
5
Syria
5
China
5
Mozambique
5
Benin
5
Tajikistan
5
Russia
5
USA
4
Cameroon
4
South Sudan
4
Indonesia
4
Peru
4
East and Southern Africa
4
Albania
4
Germany
3
Eswatini/ Swaziland
3
West and Central Africa
3
Venezuela
3
Georgia
3
Vietnam
3
Somalia
2
Central African Republic
2
El Salvador
2
Mexico
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Bhutan
2
Laos
2
Moldova
2
Jamaica
2
Guinea
1
Iraq
1
Afghanistan
1
Lebanon
1
Sudan
1
Argentina
1
Brazil
1
Colombia
1
Libya
1
Sri Lanka
1
Chile
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Palestine
1
Armenia
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
629
Clinical Guidelines
118
Public Health
41
Key Resources
38
Women & Child Health
35
Pharmacy & Technologies
33
Capacity Building
13
Toolboxes
HIV
176
TB
134
AMR
102
Mental Health
72
COVID-19
72
Pharmacy
64
NTDs
54
Ebola & Marburg
25
NCDs
24
Rapid Response
22
Caregiver
21
Health Financing Toolbox
17
Planetary Health
16
Malaria
15
Global Health Education
12
Conflict
11
Refugee
11
2.0 Rapid Response
10
Disability
9
Zika
7
Polio
5
Natural Hazards
4
Specific Hazards
4
Cholera
1
Social Ethics
1
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for
...
The goal of this assessment is to determine how far USAID/Senegal’s HIV/AIDS and TB programs have achieved their specific objectives with regard to identifying potential leads for improvement that are likely to make it easier to reach the planned results. After responding to the issues developed i
...
Buruli ulcer (BU), a neglected tropical disease (NTD), is an infection of the skin and subcutaneous tissue caused by Mycobacterium ulcerans. The disease has been documented in many South American, Asian, and Western Pacific countries and is widespread throughout much of Africa, especially in West
...
BMC Infectious Diseases (2024) 24:1102
Communities living along the shoreline and on the islands of Lake Victoria in northwestern Tanzania
remain endemic for schistosomiasis and suffer from the life-threatening morbidities associated with the disease.
Rwanda Guidelines for variation to registered pharmaceutical products.
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot
...
One important application of digital health in TB patient care is the support that it can lend to medication adherence. TB programmes have already been using short message service (SMS), video-supported treatment (VOT) and event monitoring device for medication support
...
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt
...